Phenominer Database Results (6 hits)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary gland terminal end bud count control condition Lella V, et al., Int J Cancer. 2007 Oct 15;121(8):1738-43. mammary gland development trait female 55 days 5 60.3 null 4.9 10.96 ex vivo light microscopy 0 0 66137 709
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm post-insult time to mammary tumor formation 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 99 days-104 days 46 45.91 d 0.19 1.27 manual palpation method 0 DMBA oral gavage 0 11345 73
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 46 7.61 null 0.45 3.05 manual palpation method 0 DMBA oral gavage 133 days 11356 74
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 99 days-120 days 46 0.79 cm/week 0.01 0.05 unspecified method 0.0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11348 73
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor growth rate 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 52 0.73 cm/week 0.03 0.22 unspecified method 0 DMBA oral gavage 0 the first 3 weeks of tumor growth 11511 74
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) Stieber D, et al., Int J Cancer. 2007 Jan 17 mammary gland integrity trait female 186 days-191 days 46 7.61 null 0.07 0.45 necropsy 0 DMBA oral gavage 0 necropsy 11342 73